This issue of PATH’s program e-newsletter spotlights our latest publications, advocacy news, and program
updates.
New publications
The January 2008 issue of Directions in Global Health features our work on tuberculosis control, the Uniject™
device, innovative vaccine-delivery approaches, condom promotion, and procurement.
Findings from an assessment in four states in
India indicate that services for populations at risk of HIV and unintended pregnancy can be strengthened by converging HIV and sexual and
reproductive health services.
A
new brochure outlines our work
supporting global tuberculosis control efforts: strengthening policies and professional networks as
well as building staff capacity and laboratory systems.
The latest issue of Outlook summarizes issues
related to transmission of human papillomavirus (HPV), new HPV vaccines, and strategies for vaccine introduction in developing countries.
Results from a pilot introduction project in Kenya for the nevirapine infant-dose pouch support its use in
programs working to prevent mother-to-child transmission of HIV.
A new fact sheet
addresses the future of vaccine development.
View other new and noteworthy publications from PATH.
Policy and advocacy update
PATH promotes US support for innovative financing of vaccines. PATH president Christopher Elias
moderated a congressional briefing highlighting the
need for innovative financing mechanisms for new global health technologies. Senator Richard G. Lugar (R-IN) joined global health leaders to
encourage US support of the approach.
PATH supports legislation to address gender-based violence. PATH is urging passage of new legislation aimed at enhancing and integrating violence-prevention activities in US foreign-assistance programs. The International Violence Against Women Act (S.2279) draws on evidence from a 2005 landmark study co-authored by
PATH, the World Health Organization, and the London School of Hygiene and Tropical Medicine.
Malaria prevention message shared with government leaders. Dr. Chilandu Mukuka, deputy coordinator of
Zambia’s National Malaria Programme and partner with the Malaria Control and Evaluation Partnership in Africa (MACEPA) at PATH, joined our
staff and other partners on Capitol Hill to educate US policymakers about the toll malaria takes in Africa and the commitment needed to address the
disease.
Marking a milestone in global health. More than 150 policymakers, partners, and
supporters recently gathered in PATH’s Washington, DC, office to celebrate our 30th anniversary. To mark the occasion, Representative Adam
Smith (D-WA) introduced a statement in the
Congressional Record recognizing PATH’s three decades of work in global health.
Program highlights
Unique collaboration provides packaging solution for antiretroviral drug. The
nevirapine infant-dose pouch developed by PATH will now be included in Boehringer
Ingelheim’s Viramune® Donations Program—an initiative that provides eligible countries
with oral doses of the drug that helps prevent mother-to-child transmission of HIV.
New center will advance diagnostic tests. With funding from the National Institutes of
Health, PATH and partners from the University of Washington will establish a center to support the
development of diagnostic technologies for low-resource settings.
|
|
|
